UNSPSC 51313104: Homochlorcyclizine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C19H23ClN2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N5MVC31W2N, chemically known as 1-(p-chloro-.alpha.-phenylbenzyl)hexahydro-4-methyl-1h-1, 4-diazepine, dihydrochloride but generally known as homochlorcyclizine, which bears US NIH Compound Identifier 3627. European Medicines Agency schedules Homochlorcyclizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08050MIG.

UNSPSC 51313104 Homochlorcyclizine is a Commodity code with little recent relevant activity in state and local procurement. The single recent opportunity tagged to this code — Seminole County, Florida's IFB 60459723LAS — solicits naloxone and drug deactivation systems, products outside the scope of the code's pharmaceutical classification. The mismatch suggests the opportunity was miscoded or the code does not reflect current state and local buying patterns under this narrow pharmaceutical taxonomy tier.

No additional recent state and local solicitations under this Commodity code appear in the source. Given the sparse activity and the thematic disconnect between the code's name and the one opportunity present, pursuing this code as a market segment carries limited near-term opportunity signal. Vendors serving state and local health and safety procurement may benefit from monitoring related broader pharmaceutical and medical-supply codes rather than expecting sustained activity under this specific Commodity classification.